Clinical trials: Poly Cystic Ovary Syndrome
PCOS
Furocyst - Poly Cystic Ovary Syndrome Study
Poly cystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting approximately 5%-10% of all females worldwide .
- Trial name
- NCT02703064
- Testing
- Furocyst
- Where
- India
- Volunteers
- 107 people, healthy volunteers welcome
- Sponsor
- Chemical Resources
Poly Cystic Ovary Syndrome
Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome
Poly cystic ovary syndrome (PCOS) is a disease which is prevalent in women of reproductive age facing obesity along with increased risk of type-2 diabetes and high cholesterol levels.
- Trial name
- NCT02789488
- Testing
- Fenugreek seeds extract 500 mg
- Volunteers
- 50 people
- Sponsor
- Chemical Resources